Cue Biopharma Financial Ratios for Analysis 2015-2024 | CUE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Income Statement Balance Sheet Cash Flow Stmt Key Financial Ratios

Fifteen years of historical annual and quarterly financial ratios and margins for Cue Biopharma (CUE).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share

2023	2022	2021	2020	2019	2018	2017	2016	2015
3.01	6.68	5.35	5.36	5.24	6.53	12.17	14.18	19.01
0.10	0.11	-	-	-	-	-	-	-
0.22	0.15	-	-	-	-	-	-	-
100.00	100.00	100.00	100.00	100.00	100.00	-	-	-
-949.89	-4,275.10	-292.56	-1,427.96	-1,063.21	-3,386.71	-	-	-
-949.89	-4,275.10	-292.56	-1,427.96	-1,063.21	-3,386.71	-	-	-
-943.35	-4,224.34	-284.17	-1,391.79	-1,041.86	-3,320.19	-	-	-
-924.10	-4,257.83	-292.25	-1,413.26	-1,049.25	-3,339.33	-	-	-
-924.10	-4,257.83	-295.56	-1,419.79	-1,061.18	-3,411.53	-	-	-
0.09	0.01	0.18	0.03	0.05	0.03	-	-	-
-	-	-	-	-	-	-	-	-
3.23	21.84	4.75	2.23	4.58	-	-	-	-
113	16.71	76.77	164	79.67	-	-	-	-
-136.80	-80.71	-67.43	-56.75	-67.23	-114.74	-37.71	-50.47	-27.80
-136.80	-80.71	-67.43	-56.75	-67.23	-114.74	-37.71	-50.47	-27.80
-82.45	-58.07	-52.95	-44.99	-51.25	-85.93	-34.70	-47.05	-26.37
-122.88	-71.91	-67.43	-56.75	-67.23	-114.74	-37.71	-50.47	-27.80
0.79	1.53	2.03	2.60	2.06	1.64	3.17	1.43	0.94
-0.87	-1.17	-1.24	-1.13	-1.40	-1.31	-1.13	-0.80	-0.29
-0.87	-1.18	-1.27	-1.15	-1.39	-1.40	-1.23	-0.87	-0.43

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share

2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2015-12-31
2.06	2.47	3.01	3.34	3.74	4.98	6.68	6.04	8.29	6.66	5.35	4.58	4.78	4.65	5.36	6.58	5.94	4.23	5.24	3.17	2.65	3.02	6.53	8.86	16.62	13.69	12.17	-	-	-	-	-
0.10	0.10	0.10	0.11	0.12	0.11	0.11	0.15	0.14	0.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.29	0.24	0.22	0.21	0.22	0.18	0.15	0.20	0.17	0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	-	-	-	-	-	-	-
-390.63	-737.80	-759.64	-543.76	-978.08	-7,155.08	-9,845.03	-16,222.06	-50,346.16	-1,423.80	-95.38	-543.55	-376.16	-806.05	-2,308.86	-1,439.06	-1,017.86	-1,443.89	-859.33	-720.93	-874.98	-3,088.38	-2,098.08	-2,841.65	-4,344.19	-	-	-	-	-	-	-
-390.63	-737.80	-759.64	-543.76	-978.08	-7,155.08	-9,845.03	-16,222.06	-50,346.16	-1,423.80	-95.38	-543.55	-376.16	-806.05	-2,308.86	-1,439.06	-1,017.86	-1,443.89	-859.33	-720.93	-874.98	-3,088.38	-2,098.08	-2,841.65	-4,344.19	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-382.66	-719.10	-737.73	-524.05	-954.05	-7,010.16	-9,663.58	-16,110.29	-50,800.00	-1,425.50	-95.58	-542.51	-375.28	-805.22	-2,292.47	-1,424.86	-1,007.72	-1,424.22	-850.11	-710.37	-863.41	-3,045.14	-2,065.42	-2,797.11	-4,244.19	-	-	-	-	-	-	-
-382.66	-719.10	-737.73	-524.05	-954.05	-7,010.16	-9,663.58	-16,110.29	-50,800.00	-1,425.50	-101.57	-542.51	-375.28	-805.22	-2,335.86	-1,424.86	-1,007.72	-1,424.22	-850.06	-710.37	-902.56	-3,045.14	-2,223.59	-2,797.11	-4,244.19	-	-	-	-	-	-	-
0.06	0.03	0.03	0.03	0.02	0.00	0.00	0.00	0.00	0.01	0.10	0.03	0.03	0.02	0.00	0.01	0.01	0.01	0.01	0.02	0.03	0.01	0.01	0.01	0.00	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1.44	1.23	1.07	1.26	1.22	0.95	2.65	0.09	0.04	0.17	2.63	3.11	1.44	1.10	0.34	1.54	0.88	1.49	1.39	1.61	2.02	-	-	-	-	-	-	-	-	-	-	-
62.54	73.38	83.92	71.19	73.91	94.33	33.97	1,054	2,548	545	34.26	28.97	62.56	81.89	268	58.42	103	60.50	64.75	55.79	44.53	-	-	-	-	-	-	-	-	-	-	-
-47.04	-41.10	-36.22	-25.79	-28.66	-23.83	-22.22	-21.58	-22.10	-22.04	-12.80	-20.46	-14.10	-17.95	-14.07	-11.46	-13.52	-28.34	-16.34	-25.87	-46.95	-45.55	-34.14	-31.87	-14.83	-13.62	-16.95	-	-	-	-	-
-47.04	-41.10	-36.22	-25.79	-28.66	-23.83	-22.22	-21.58	-22.10	-22.04	-12.80	-20.46	-14.10	-17.95	-14.07	-11.46	-13.52	-28.34	-16.34	-25.87	-46.95	-45.55	-34.14	-32.01	-14.88	-13.66	-16.95	-	-	-	-	-
-24.03	-22.89	-21.83	-15.98	-18.02	-16.05	-15.99	-14.36	-15.58	-15.72	-10.05	-16.47	-11.46	-14.09	-11.15	-9.41	-10.69	-21.13	-12.46	-15.46	-22.80	-24.93	-25.57	-28.17	-13.74	-12.68	-15.60	-	-	-	-	-
-42.54	-37.10	-32.54	-23.01	-25.30	-21.11	-19.79	-18.33	-18.96	-19.13	-12.80	-20.46	-14.10	-17.95	-14.07	-11.46	-13.52	-28.34	-16.34	-25.87	-46.95	-45.55	-34.14	-31.87	-14.83	-13.62	-16.95	-	-	-	-	-
0.44	0.62	0.79	0.95	1.05	1.27	1.53	1.43	1.69	1.89	2.03	2.03	2.32	2.28	2.60	2.89	2.74	1.70	2.06	1.18	0.98	1.19	1.64	1.96	2.45	2.74	3.17	-	-	-	-	-
-0.39	-0.20	-0.87	-0.63	-0.47	-0.24	-1.17	-0.88	-0.69	-0.35	-1.24	-0.90	-0.69	-0.39	-1.13	-0.86	-0.63	-0.41	-1.40	-1.09	-0.73	-0.41	-1.31	-1.12	-0.81	-0.49	-1.14	-0.97	-0.62	-0.33	0.00	0.00
-0.40	-0.20	-0.87	-0.63	-0.47	-0.24	-1.18	-0.89	-0.69	-0.36	-1.27	-0.93	-0.72	-0.41	-1.15	-0.88	-0.64	-0.41	-1.39	-1.08	-0.72	-0.41	-1.40	-1.20	-0.88	-0.52	-1.23	-1.06	-0.70	-0.38	-	-